Evidence map›Paper›PMID 37594544›Full record

SynthesisEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2023

Characteristics of sudden hearing loss after different COVID-19 vaccinations: a systematic review and meta-analysis.

Khaled Albakri, Omar Ahmed Abdelwahab, Mohamed Diaa Gabra, Mohamed H Nafady, Yasmeen Jamal Alabdallat, Ahmed Soliman, Shirin Cadri, Balqees Hanaqtah, Ebraheem Albazee

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 4 countries.

Khaled AlbakriFaculty of Medicine, The Hashemite University, Zarqa, Jordan.
Omar Ahmed AbdelwahabMedical Research Group of Egypt, Cairo, Egypt.
Mohamed Diaa GabraMedical Research Group of Egypt, Cairo, Egypt.
Mohamed H NafadyMedical Research Group of Egypt, Cairo, Egypt.
Yasmeen Jamal AlabdallatFaculty of Medicine, The Hashemite University, Zarqa, Jordan.
Ahmed SolimanMedical Research Group of Egypt, Cairo, Egypt. ahmedsolimann9090@gmail.com.ORCID http://orcid.org/0000-0003-3964-3778
Shirin CadriMedical Research Group of Egypt, Cairo, Egypt.
Balqees HanaqtahFaculty of Medicine, The Hashemite University, Zarqa, Jordan.
Ebraheem AlbazeeMedical Research Group of Egypt, Cairo, Egypt.
Hashemite University · JOAl-Azhar University · EGGrigore T. Popa University of Medicine and Pharmacy · ROKuwait Institute for Medical Specialization · KWMansoura University · EGMisr University for Science and Technology · EGSouth Valley University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCOVID-19 vaccines are essential to prevent complications and reduce the burden of SARS-CoV-2. However, these vaccines showed side effects such as fatigue, pain, fever, and rarely hearing loss. In this review, we aim to summarize studies investigating hearing loss following COVID-19 vaccination and try to find the possible association and risk factors for this hazardous complication.

methodsWe performed a comprehensive search of five electronic databases (PubMed, Scopus, Web of Science, google scholar, Cochrane) from inception until 9 October 2022. We finally included 16 studies after the first and second scans. We used SPSS to analyze the extracted data.

resultsA total of 630 patients were identified, with a mean age of 57.3. Of the patients, 328 out of 609 vaccinated patients took the Pfizer-BioNTech BNT162b2 vaccine, while 242 (40%) took the Moderna COVID-19 vaccine. The mean time from vaccination to hearing impairment was 6.2, ranging from a few hours to one month after the last dose. The results found a significant difference between vaccine types in terms of incidence and prognosis of the condition, while they showed that the number of doses prior to the onset had no significance.

conclusionSNHL has been reported in a small number of people who have received the COVID-19 vaccine, but it is unclear at this time whether the vaccine is directly causing this condition. However, the COVID-19 vaccine has been demonstrated to be safe and effective in preventing illness, and the benefits of vaccination are significant compared to any potential risks. PROTOCOL REGISTRATION: The protocol of this study was registered on Prospero CRD42022367180.

Indexed as

COVID-19DeafnessHearing Loss, Sudden2019-nCoV Vaccine mRNA-1273BNT162 VaccineCOVID-19 VaccinesHumansMiddle AgedSARS-CoV-2Vaccination2019-nCoV Vaccine mRNA-1273BNT162 VaccineCOVID-19 VaccinesCOVID-19Hearing lossSide effectsVaccine

Identifiers

PMID37594544
OpenAlexW4385969782

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.